中国P站

The field of proteomics and biopharmaceutical characterization heavily relies on advanced analytical techniques, with peptide mapping emerging as a cornerstone for detailed protein analysis. Recent advancements have significantly enhanced the capabilities of these methods, leading to improved understanding of protein structures and their modifications. A high-throughput capillary-liquid chromatography-mass spectrometry (Capillary-LC-MS) method has been developed to improve both throughput and sensitivity in peptide mapping, proving useful for characterizing protein higher-order structures, disulfide bonds, and post-translational modifications, which are critical for understanding protein biology [1].

Multi-attribute peptide mapping has become a robust quality control (QC) tool, particularly for recombinant protein pharmaceuticals. This methodology excels at accurately identifying and quantifying critical quality attributes, an essential function for ensuring drug safety and efficacy throughout the entire development and manufacturing lifecycle [2].

Further enhancing comprehensive peptide mapping, a novel high-resolution data-independent acquisition (DIA) strategy has been evaluated. This strategy markedly improves the detection and identification of various peptides, including those of low abundance and with diverse post-translational modifications, marking a powerful step forward for detailed protein characterization [3].

Innovations in instrumentation have also driven progress, as exemplified by single-shot peptide mapping workflows employing trapped ion mobility spectrometry-mass spectrometry (TIMS-MS). This approach offers enhanced resolving power and sensitivity, enabling more in-depth characterization of biopharmaceuticals and complex protein samples within a single analytical run [4].

The integration of microfluidic platforms represents another significant advancement, with a workflow for high-throughput multi-attribute peptide mapping using the ZipChip microfluidic platform. This method substantially reduces sample preparation and analysis time, which is invaluable for rapid quality control and accelerating early-stage biopharmaceutical development processes [5].

Computational methods are increasingly playing a vital role, as seen in the application of deep learning for predicting peptide retention times in LC-MS peptide mapping. This computational strategy has dramatically improved the accuracy of peptide identification and quantification, thereby streamlining data analysis and enhancing the efficiency and reliability of peptide mapping workflows [6].

Beyond traditional methods, hybrid approaches are also gaining traction, such as combining top-down and bottom-up peptide mapping using capillary zone electrophoresis-mass spectrometry (CZE-MS). This technique is particularly effective for the comprehensive characterization of recombinant antibodies, providing detailed insights into their primary structure and various post-translational modifications [7].

The continuous refinement of established techniques remains crucial. An efficient peptide mapping workflow leveraging advanced liquid chromatography and high-resolution mass spectrometry has been demonstrated. This method yields detailed structural information vital for biopharmaceutical quality control and comparability studies throughout drug development [8].

Automation has also been a key area of improvement, with the introduction of a simplified, automated peptide mapping workflow utilizing a high-throughput microfluidic device. This innovation significantly reduces manual labor and sample processing time, rendering it ideal for routine analysis and boosting overall laboratory efficiency in biopharmaceutical characterization [9].

Finally, the versatility of capillary electrophoresis-mass spectrometry (CE-MS) for advanced peptide mapping continues to be explored. This method provides excellent resolution and sensitivity, proving particularly beneficial for detailed characterization and accurate quantitation of complex peptide mixtures, including those derived from therapeutic proteins [10].

Description

Peptide mapping is a fundamental technique in proteomic analysis, offering detailed insights into protein primary structure, post-translational modifications, and higher-order structural attributes. Advancements in this area are continuous, driven by the need for greater sensitivity, throughput, and accuracy. One significant development is a high-throughput capillary-liquid chromatography-mass spectrometry method that enhances both analytical speed and detection limits, making it indispensable for detailed structural analysis of proteins, including the identification of intricate disulfide bonds and various post-translational modifications [1]. For recombinant protein pharmaceuticals, the implementation of multi-attribute peptide mapping serves as a critical quality control measure. This method is specifically designed to precisely identify and quantify key quality attributes, ensuring the product meets rigorous safety and efficacy standards throughout its entire lifecycle, from early development to commercial manufacturing [2]. Further improvements in comprehensive peptide mapping are highlighted by a novel high-resolution data-independent acquisition (DIA) strategy. This innovative approach has been shown to substantially enhance the detection and identification of a wide range of peptides, including those present at low concentrations and those bearing complex post-translational modifications, thereby providing a more complete picture of protein characteristics [3]. The evolution of peptide mapping workflows also includes the integration of advanced instrumentation such as trapped ion mobility spectrometry-mass spectrometry (TIMS-MS). Single-shot workflows utilizing TIMS-MS offer superior resolving power and heightened sensitivity, facilitating a more exhaustive characterization of intricate biopharmaceutical and protein samples within a single analytical run, which is crucial for efficient research and development [4]. Microfluidic technologies are transforming sample handling and analysis, as demonstrated by an integrated workflow for high-throughput multi-attribute peptide mapping on the ZipChip microfluidic platform. This system remarkably diminishes the time required for sample preparation and subsequent analysis, proving invaluable for expedited quality control procedures and accelerating the initial stages of biopharmaceutical development [5]. The realm of data processing has seen revolutionary changes with the introduction of deep learning for predicting peptide retention times in LC-MS peptide mapping. This advanced computational method significantly boosts the accuracy of peptide identification and quantification, effectively streamlining complex data analysis and contributing to more efficient and reliable peptide mapping workflows overall [6]. Hybrid analytical strategies are expanding the scope of protein characterization, such as the combined top-down and bottom-up peptide mapping approach using capillary zone electrophoresis-mass spectrometry (CZE-MS). This dual strategy is particularly effective for the exhaustive characterization of recombinant antibodies, providing an unparalleled level of detail regarding their primary structure and post-translational modifications, which are crucial for therapeutic protein understanding [7]. Continued innovation in core chromatographic and mass spectrometric techniques underpins many of these advances. An efficient peptide mapping workflow employing advanced liquid chromatography and high-resolution mass spectrometry offers precise structural insights into biopharmaceuticals. This detailed information is indispensable for rigorous quality control assessments and for conducting thorough comparability studies during various phases of drug development [8]. Automation remains a key driver for efficiency in analytical laboratories. A simplified and automated peptide mapping workflow using a high-throughput microfluidic device substantially reduces the need for manual intervention and decreases overall sample processing time. This makes the system ideal for routine analyses, thereby enhancing the operational efficiency of laboratories involved in biopharmaceutical characterization [9]. Capillary electrophoresis-mass spectrometry (CE-MS) continues to be a powerful technique for advanced peptide mapping, delivering exceptional resolution and sensitivity. This method is especially advantageous for the detailed characterization and precise quantitation of complex peptide mixtures, including those derived from critical therapeutic proteins, ensuring high-fidelity results in demanding analytical applications [10].

Conclusion

The provided research highlights significant advancements in peptide mapping techniques across various platforms and applications. Innovations include high-throughput capillary-liquid chromatography-mass spectrometry for characterizing protein higher-order structures and post-translational modifications. Multi-attribute peptide mapping has been established as a robust quality control tool for recombinant protein pharmaceuticals, ensuring drug safety and efficacy. Novel high-resolution data-independent acquisition strategies enhance peptide detection, particularly for low-abundance peptides and modifications. Single-shot workflows utilizing trapped ion mobility spectrometry-mass spectrometry improve resolving power and sensitivity for biopharmaceutical analysis. Integrated microfluidic platforms significantly reduce sample preparation and analysis time, beneficial for rapid quality control. Deep learning applications are streamlining data analysis by predicting peptide retention times, thereby increasing accuracy and efficiency. Hybrid top-down and bottom-up approaches using capillary zone electrophoresis-mass spectrometry provide comprehensive characterization of recombinant antibodies. Efficient liquid chromatography and high-resolution mass spectrometry workflows offer vital structural information for biopharmaceutical quality control. Automated microfluidic devices reduce manual labor and processing time, enhancing laboratory efficiency. Finally, capillary electrophoresis-mass spectrometry continues to provide excellent resolution and sensitivity for complex peptide mixture characterization and quantitation, crucial for therapeutic protein analysis. These collective advancements underscore a continuous drive toward more sensitive, efficient, and comprehensive protein characterization.

References

1. Hongbo L, Yujie D, Bo Y. (2024) .Anal Chem 96:5701-5707.

   , ,

2. Qiao-Wen W, Shuai Z, Qing-Lan G. (2023) .J Chromatogr A 1708:464295.

   , ,

3. Aaron DS, Stephanie MD, Sean ML. (2023) .J Am Soc Mass Spectrom 34:477-487.

   , ,

4. Stephen KB, Daniel SP, Daniel JK. (2022) .Anal Chem 94:5770-5777.

   , ,

5. Christopher TL, David HS, Eric DZS. (2022) .J Chromatogr B 1208:123389.

   , ,

6. Alex TMN, Andrew SST, Yuen L. (2021) .J Proteome Res 20:3585-3595.

   , ,

7. Janette H, Michael GHRJdK, Peter JvdV. (2021) .Anal Chem 93:7376-7383.

   , ,

8. Kevin H, Jonathan RY, Michael GG. (2020) .J Pharm Sci 109:2263-2273.

   , ,

9. Jun L, Ming-liang T, Fan G. (2020) .J Am Soc Mass Spectrom 31:1687-1694.

   , ,

10. Guodong C, Min Z, Ling C. (2019) .Anal Chem 91:11083-11088.

    , ,